Regenxbio News, Regenxbio Quote, RGNX Quote

Regenxbio (NQ:RGNX) Delayed: 15.19 -0.04 (0.26%)

Prev. Close

$15.23

Today 6M 1Y 5Y

Open

$15.37

52 Wk High

$25.00

52 Wk Low

$7.07

Day High

$15.75

Day Low

$14.92

P/E

N/A

EPS

$0.00

Volume

952,595

Friends, Peers and Foes (?): QURE, CAPR, IMTX, KRYS, RVMD (more...)

ALERTS | RSS

Jul 6, 2026 04:52 PM Form 4 REGENXBIO Inc. For: Dec 31 Filed by: Simpson Curran
Jul 6, 2026 04:51 PM Form 4 REGENXBIO Inc. For: Jul 02 Filed by: PAKOLA STEVE
Jul 6, 2026 08:01 AM Form SC TO-I/A REGENXBIO Inc. Filed by: REGENXBIO Inc.
Jul 1, 2026 08:09 PM Form 4 REGENXBIO Inc. For: Jun 29 Filed by: PAKOLA STEVE
Jul 1, 2026 04:32 PM Form 144 REGENXBIO Inc. Filed by: PAKOLA STEVE
Jul 1, 2026 09:11 AM Form SC TO-I/A REGENXBIO Inc. Filed by: REGENXBIO Inc.
Jul 1, 2026 07:00 AM H.C. Wainwright Reiterates Buy Rating on Regenxbio Inc. (RGNX)
Jun 29, 2026 07:15 AM Form 8-K REGENXBIO Inc. For: Jun 23
Jun 29, 2026 07:05 AM Regenxbio doses first patient in diabetic retinopathy gene therapy trial
Jun 29, 2026 07:05 AM REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone

Entities mentioned with RGNX

View All Entities